Tao Ouyang

Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

Zefei Jiang, Wei Li, Xichun Hu et al. · The Lancet Oncology · 2019 · 267 citations

Medicine, Oncology, Pharmacology +14

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment

Ye Xu, Yu Sun, Lei Yao et al. · Annals of Oncology · 2008 · 179 citations

Medicine, Oncology, Pharmacology +10

p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Ye Xu, Lihua Yao, Tao Ouyang et al. · Clinical Cancer Research · 2005 · 102 citations

Medicine, Molecular Genetics, Oncology +15

Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in <i>BRCA1</i> Mutation Carriers

Li Hu, Liming Su, Hainan Cheng et al. · Cancer Research · 2021 · 86 citations · Full text

Life Sciences, Genetics, Oncology +17

<i>HER2</i> somatic mutations are associated with poor survival in HER2‐negative breast cancers

Tonghui Wang, Ye Xu, Shuyan Sheng et al. · Cancer Science · 2017 · 67 citations · Full text

Medicine, Genetics, Oncology +17